Zidovudine safety and tolerance among uninfected healthcare workers: a brief update.
Beekmann
S E
SE
National Institutes of Health, Bethesda, Maryland, USA.
Fahrner
R
R
Henderson
D K
DK
Gerberding
J L
JL
D019380:Anti-HIV Agents / Q000009:adverse effects*; D015986:Confounding Factors, Epidemiologic; D015658:HIV Infections / Q000209:etiology / Q000517:prevention & control*; D006282:Health Personnel; D006801:Humans; D016273:Occupational Exposure / Q000009:adverse effects*; D011446:Prospective Studies; D012107:Research Design; D015215:Zidovudine / Q000009:adverse effects*
D019380:Anti-HIV Agents; D015215:Zidovudine